IL17A and neoplasm: Interestingly, these pro- and antitumor effects were successfully reproduced in wild-type mice through administration of either recombinant IL-17 (which accelerated tumor growth) or antibody-mediated IL-17 blockade (which suppressed it), hinting at the viability of anticancer therapies targeting this pathway (47).